SCHEMBL21628513

SCHEMBL21628513

O=C(O)c1ccc(Oc2ccc(C(F)(F)C(F)(F)F)cc2)c(F)c1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
IGFBP3 P17936 4/20 0.52
LMNA P02545 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
TTR P02766 2/20 0.46
LPAR1 Q92633 2/20 0.42
LPAR5 Q9H1C0 2/20 0.42
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
PARP10 Q53GL7 1/20 0.41
FFAR1 O14842 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628798 0.92 LMNA (0.49) IGFBP3LMNAMAPK1HTTRAB9A
SCHEMBL21628455 0.91 LMNA (0.48) IGFBP3LMNAMAPK1HTTRAB9A
SCHEMBL21628817 0.89 LMNA (0.51) IGFBP3LMNAMAPK1HTTRAB9A
SCHEMBL21656739 0.89 IGFBP3 (0.59) IGFBP3LMNAMAPK1HTTRAB9A
SCHEMBL21628807 0.88 PARP10 (0.54) IGFBP3KDM4EMAPTPARP10
SCHEMBL21628770 0.85 ALDH1A1 (0.51) IGFBP3LMNAMAPK1HTTRAB9A
SCHEMBL21628839 0.85 OPRM1 (0.45) IGFBP3MAPK1KDM4EMAPT
SCHEMBL19357374 0.84 RAB9A (0.56) IGFBP3LMNAMAPK1HTTRAB9A
SCHEMBL21628649 0.84 HPGD (0.51) IGFBP3MAPK1HTTKDM4EMAPT
SCHEMBL21628846 0.84 SLC6A2 (0.53) IGFBP3LMNAMAPK1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK IGFBP3 2998/4885LMNA 3083/4885MAPK1 3401/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR IGFBP3 1912/4885LMNA 832/4885MAPK1 2406/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK IGFBP3 3214/4885LMNA 3327/4885MAPK1 3508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.